| [1] |
Van Hagen P, Hulshof MC, van Lanschot JJ，et al. Preoperative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med，2012，366(22)：2074-2084.
|
| [2] |
Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicentre phase Ⅲ trial[J]. J Clin Oncol，2011，29(13)：1715-1721.
|
| [3] |
Cunningham D, Allum WH, Stenning SP，et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer[J]. N Engl J Med，2006，355(1)：11-20.
|
| [4] |
Allum WH, Stenning SP, Bancewicz J，et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer[J]. J Clin Oncol，2009，27(30)：5062-5067.
|
| [5] |
Markar SR, Mackenzie H, Lagergren P，et al. Surgical proficiency gain and survival after esophagectomy for cancer[J]. J Clin Oncol，2016，34(13): 1528-1536.
|
| [6] |
Mak RH, Mamon HJ, Ryan DP，et al. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older[J]. Dis Esophagus，2010，23(4)：316-323.
|
| [7] |
Markar S, Gronnier C, Duhamel A, et al. The impact of severe anastomotic leak on long-term survival and cancer recurrence after surgical resection for esophageal malignancy[J]. Ann Surg，2015，262(6)：972-980.
|
| [8] |
Van der Schaaf M, Derogar M, Johar A ，et al. Reoperation after oesophageal cancer surgery in relation to long-term survival: a population-based cohort study[J]. BMJ Open，2014，4(3)：e004648.
|
| [9] |
Rutergard M, Lagergren P, Rouvelas I, et al. Surgical com-plications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study[J]. Eur J Surg Oncol，2012，38(7)：555-561.
|
| [10] |
Robb WB, Messager M, Gronnier C，et al. High-grade toxicity to neoadjuvant treatment for upper gastrointestinal carcinomas：What is the impact on perioperative and oncologic outcomes？[J]Ann Surg Oncol，2015，22(11)：3632-3639.
|
| [11] |
Armitage JN, vander Meulen JH. Royal College of Surgeons Comorbidity Consensus Group Identifying comorbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score[J]. Br J Surg，2010，97(5)：772-781.
|
| [12] |
Lagergren J, Bergstrom R, Lindgren A，et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma[J]．N Engl J Med，1999，340(11)：825-831.
|
| [13] |
Derogar M, Sadr-Azodi O, Johar A，et al. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study[J]. J Clin Oncol，2013，31(5)：551-557.
|
| [14] |
Swisher SG, Holmes EC, Hunt K K，et al. Perioperative blood transfusions and decreased long-term survival in esophageal cancer[J]. J Thorac Cardiovasc Surg，1996，112(2)：341-348.
|
| [15] |
Tachibana M, Tabara H, Kotoh T，et al. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer[J]. Am J Gastroenterol，1999，94(3): 757-765.
|